rs9649959

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000513868.6(PVT1):​n.540+20799A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.289 in 151,974 control chromosomes in the GnomAD database, including 6,841 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.29 ( 6841 hom., cov: 31)

Consequence

PVT1
ENST00000513868.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 2.18

Publications

8 publications found
Variant links:
Genes affected
PVT1 (HGNC:9709): (Pvt1 oncogene) This gene represents a long non-coding RNA locus that has been identified as a candidate oncogene. Increased copy number and overexpression of this gene are associated with many types of cancers including breast and ovarian cancers, acute myeloid leukemia and Hodgkin lymphoma. Allelic variants of this gene are also associated with end-stage renal disease attributed to type 1 diabetes. Consistent with its association with various types of cancer, transcription of this gene is regulated by the tumor suppressor p53 through a canonical p53-binding site, and it has been implicated in regulating levels of the proto-oncogene MYC to promote tumorigenesis. [provided by RefSeq, Sep 2015]
MIR1205 (HGNC:35271): (microRNA 1205) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.333 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PVT1NR_003367.4 linkn.790+20799A>G intron_variant Intron 3 of 8
PVT1NR_186119.1 linkn.955+20799A>G intron_variant Intron 4 of 14
PVT1NR_186120.1 linkn.905+20799A>G intron_variant Intron 4 of 14

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PVT1ENST00000513868.6 linkn.540+20799A>G intron_variant Intron 2 of 7 1
PVT1ENST00000844666.1 linkn.26A>G non_coding_transcript_exon_variant Exon 1 of 5
PVT1ENST00000844780.1 linkn.26A>G non_coding_transcript_exon_variant Exon 1 of 5

Frequencies

GnomAD3 genomes
AF:
0.288
AC:
43802
AN:
151856
Hom.:
6831
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.199
Gnomad AMI
AF:
0.345
Gnomad AMR
AF:
0.280
Gnomad ASJ
AF:
0.283
Gnomad EAS
AF:
0.132
Gnomad SAS
AF:
0.315
Gnomad FIN
AF:
0.397
Gnomad MID
AF:
0.326
Gnomad NFE
AF:
0.337
Gnomad OTH
AF:
0.311
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.289
AC:
43852
AN:
151974
Hom.:
6841
Cov.:
31
AF XY:
0.291
AC XY:
21615
AN XY:
74290
show subpopulations
African (AFR)
AF:
0.199
AC:
8234
AN:
41434
American (AMR)
AF:
0.281
AC:
4291
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.283
AC:
982
AN:
3472
East Asian (EAS)
AF:
0.132
AC:
682
AN:
5160
South Asian (SAS)
AF:
0.316
AC:
1513
AN:
4794
European-Finnish (FIN)
AF:
0.397
AC:
4197
AN:
10566
Middle Eastern (MID)
AF:
0.337
AC:
99
AN:
294
European-Non Finnish (NFE)
AF:
0.337
AC:
22872
AN:
67938
Other (OTH)
AF:
0.316
AC:
667
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.523
Heterozygous variant carriers
0
1561
3123
4684
6246
7807
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
442
884
1326
1768
2210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.302
Hom.:
2647
Bravo
AF:
0.272
Asia WGS
AF:
0.236
AC:
821
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
18
DANN
Benign
0.66
PhyloP100
2.2

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9649959; hg19: chr8-128972721; COSMIC: COSV68680571; API